<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36030055</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2667-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Journal of the Academy of Consultation-Liaison Psychiatry</Title><ISOAbbreviation>J Acad Consult Liaison Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Neurocircuitry Hypothesis and Clinical Experience in Treating Neuropsychiatric Symptoms of Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2.</ArticleTitle><Pagination><StartPage>619</StartPage><EndPage>627</EndPage><MedlinePgn>619-627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaclp.2022.08.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2667-2960(22)00309-3</ELocationID><Abstract><AbstractText>Persistent symptoms following COVID-19 infection have been termed postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Many of these symptoms are neuropsychiatric, such as inattention, impaired memory, and executive dysfunction; these are often colloquially termed "brain fog". These symptoms are common and often persist long after the acute phase. The pattern of these deficits combined with laboratory, neuroimaging, electroencephalographic, and neuropsychological data suggest that these symptoms may be driven by direct and indirect damage to the frontal-subcortical neural networks. Here, we review this evidence, share our clinical experience at an academic medical center, and discuss potential treatment implications. While the exact etiology remains unknown, a neurocircuit-informed understanding of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection can help guide pharmacology, neuromodulation, and physical and psychological therapeutic approaches.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Newhouse</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Department of Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: anewhouse@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kritzer</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eryilmaz</LastName><ForeName>Hamdi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Praschan</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camprodon</LastName><ForeName>Joan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fricchione</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chemali</LastName><ForeName>Zeina</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 MH112485</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Acad Consult Liaison Psychiatry</MedlineTA><NlmUniqueID>101775059</NlmUniqueID><ISSNLinking>2667-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">long-Covid</Keyword><Keyword MajorTopicYN="N">neurobiology</Keyword><Keyword MajorTopicYN="N">neuropsychiatry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36030055</ArticleId><ArticleId IdType="pmc">PMC9404079</ArticleId><ArticleId IdType="doi">10.1016/j.jaclp.2022.08.007</ArticleId><ArticleId IdType="pii">S2667-2960(22)00309-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fernandes L.A., Garcia Ribeiro C., Martins M., et al. Prevalence of the most frequent neuropsychiatric diagnoses in hospitalized SARS-CoV-2 patients Evaluated by Liaison Psychiatry: cross-Sectional study. Acta med Port. 2022 doi: 10.20344/amp.16410.</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.16410</ArticleId><ArticleId IdType="pubmed">35171094</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.I., Brokstad K.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and long-term rates of Postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: a meta-analysis and systematic review. J Infect Dis. 2021 doi: 10.1101/2021.11.15.21266377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.15.21266377</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., et al. Markers of immune activation and inflammation in individuals with Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J&#xa0;Infect Dis. 2021;224:1839&#x2013;1848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple A.C., Oddi A., Peluso M.J., et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Translational Neurol. 2022;9:221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020;9:100163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46:2235&#x2013;2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Martinez L., Karten J., Kritzer M.D., et al. Post-acute sequelae of SARS-CoV-2 infection: a Descriptive clinical study. J&#xa0;Neuropsychiatry Clin Neurosci. 2022 doi: 10.1176/appi.neuropsych.21070193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.21070193</ArticleId><ArticleId IdType="pubmed">35686346</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.I., Demetriou M., et al. Long COVID and neuropsychiatric manifestations (Review) Exp Ther Med. 2022;23:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonelli R.M., Cummings J.L. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9:141&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181854</ArticleId><ArticleId IdType="pubmed">17726913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.L. Frontal-subcortical circuits and Human behavior. Arch Neurol. 1993;50:873&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">8352676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G., Todisco M., Hota N., et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28:3856&#x2013;3865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K.S., Nobili F. Is the frontal lobe the primary target of SARS-CoV-2? J&#xa0;Alzheimers Dis. 2021;81:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Ferse C., Kreye J., et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E.R., Wang B., wooi Wan Y., et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J&#xa0;Clin Invest. 2020;130:1912&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108898</ArticleId><ArticleId IdType="pubmed">31917687</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16:e0257016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez V.S., Zetter M.A., Guerra E.C., et al. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations. Exp Neurol. 2021;345:113837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361001</ArticleId><ArticleId IdType="pubmed">34400158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai J.P., Etyemez S., Jaaro-Peled H., et al. Olfactory modulation of the medial prefrontal cortex circuitry: Implications for social cognition. Semin Cell Dev Biol. 2021 doi: 10.1016/j.semcdb.2021.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2021.03.022</ArticleId><ArticleId IdType="pmc">PMC8573060</ArticleId><ArticleId IdType="pubmed">33975755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) J&#xa0;Pathol. 2020;251:228&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M.E., Madore C., Bordeleau M., Tian L., Verkhratsky A. Neuropathobiology of COVID-19: the role for Glia. Front Cell Neurosci. 2020;14:592214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Hwang Y., Lee D., Webster M.J. Transcriptome sequencing of the choroid plexus in schizophrenia. Transl Psychiatry. 2016;6:e964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290353</ArticleId><ArticleId IdType="pubmed">27898074</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guennec L., Devianne J., Jalin L., et al. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020;61:e90&#x2013;e94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361605</ArticleId><ArticleId IdType="pubmed">32589794</ArticleId></ArticleIdList></Reference><Reference><Citation>How COVID-19 affects the brain | Neurology | JAMA Psychiatry | JAMA network. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2778090</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotoxic reactive astrocytes are induced by activated microglia | Nature. https://www.nature.com/articles/nature21029</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman M., Irwin M.R. Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far. Brain Behav Immun. 2020;83:7&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6940145</ArticleId><ArticleId IdType="pubmed">31550500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cani I., Barone V., D&#x2019;Angelo R., et al. Frontal encephalopathy related to hyperinflammation in COVID-19. J&#xa0;Neurol. 2021;268:16&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7353824</ArticleId><ArticleId IdType="pubmed">32654063</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach S.R., Praschan N.C., Hogan C., et al. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020;65:47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242189</ArticleId><ArticleId IdType="pubmed">32470824</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusunyan M., Praschan N., Fricchione G., Beach S. Akinetic mutism and coronavirus disease 2019: a Narrative review. J&#xa0;Acad Consultation-Liaison Psychiatry. 2021;62:625&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8390446</ArticleId><ArticleId IdType="pubmed">34461295</ArticleId></ArticleIdList></Reference><Reference><Citation>Najt P., Richards H.L., Fortune D.G. Brain imaging in patients with COVID-19: a systematic review. Brain Behav Immun Health. 2021;16:100290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249107</ArticleId><ArticleId IdType="pubmed">34230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., Soret M., Pyatigoskaya N., et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 2021;48:2543&#x2013;2557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T., Gajera P.K., Kuroda N. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav. 2021;115:107682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833461</ArticleId><ArticleId IdType="pubmed">33342709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticinesi A., Cerundolo N., Parise A., et al. Delirium in COVID-19: epidemiology and clinical correlations in a large group of patients admitted to an academic hospital. Aging Clin Exp Res. 2020;32:2159&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498987</ArticleId><ArticleId IdType="pubmed">32946031</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrescu A.M., Taussig D., Bouilleret V. Electroencephalogram (EEG) in COVID-19: a systematic retrospective study. Neurophysiol Clin. 2020;50:155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315937</ArticleId><ArticleId IdType="pubmed">32653111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayub N., Cohen J., Jing J., et al. Clinical electroencephalography findings and Considerations in hospitalized patients with coronavirus SARS-CoV-2. Neurohospitalist. 2021;11:204&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182395</ArticleId><ArticleId IdType="pubmed">34163546</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis S., Dhawan A., Newey C., et al. Continuous electroencephalography characteristics and acute symptomatic seizures in COVID-19 patients. Clin Neurophysiol. 2020;131:2651&#x2013;2656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448875</ArticleId><ArticleId IdType="pubmed">32949985</ArticleId></ArticleIdList></Reference><Reference><Citation>Niguet J.P., Tortuyaux R., Garcia B., et al. Neurophysiological findings and their prognostic value in critical COVID-19 patients: an observational study. Clin Neurophysiol. 2021;132:1009&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906512</ArticleId><ArticleId IdType="pubmed">33743295</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony A.R., Haneef Z. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 2020;83:234&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569418</ArticleId><ArticleId IdType="pubmed">33121875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadighparvar S., Tale F., Shahabi P., Naderi S., Ghaderi Pakdel F. The response of ventral tegmental area dopaminergic Neurons to bupropion: Excitation or inhibition? Basic Clin Neurosci. 2019;10:281&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101519</ArticleId><ArticleId IdType="pubmed">32231766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkis R.A., Kaur N., Camprodon J.A. Transcranial direct current stimulation (tDCS): modulation of executive function in health and disease. Curr Behav Neurosci Rep. 2014;1:74&#x2013;85.</Citation></Reference><Reference><Citation>Eilam-Stock T., George A., Lustberg M., Wolintz R., Krupp L.B., Charvet L.E. Telehealth transcranial direct current stimulation for recovery from Post-Acute Sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2021;14:1520&#x2013;1522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514329</ArticleId><ArticleId IdType="pubmed">34655835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubreuil-Vall L., Chau P., Ruffini G., Widge A.S., Camprodon J.A. tDCS to the left DLPFC modulates cognitive and physiological correlates of executive function in a state-dependent manner. Brain Stimul. 2019;12:1456&#x2013;1463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6851462</ArticleId><ArticleId IdType="pubmed">31221553</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubreuil-Vall L., Gomez-Bernal F., Villegas A.C., et al. Transcranial direct current stimulation to the left dorsolateral prefrontal cortex improves cognitive control in patients with attention-deficit/hyperactivity disorder: a Randomized behavioral and neurophysiological study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:439&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103824</ArticleId><ArticleId IdType="pubmed">33549516</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart R.M.G., Nguyen J.A. Working memory revived in older adults by synchronizing rhythmic brain circuits. Nat Neurosci. 2019;22:820&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6486414</ArticleId><ArticleId IdType="pubmed">30962628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021;19:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8477362</ArticleId><ArticleId IdType="pubmed">34583690</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., et al. A&#xa0;core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. The Lancet Respir Med. 2022;10:715&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandolesi L., Polverino A., Montuori S., et al. Effects of physical exercise on cognitive functioning and Wellbeing: Biological and psychological benefits. Front Psychol. 2018;9:509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5934999</ArticleId><ArticleId IdType="pubmed">29755380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>